These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27071701)
1. A comparative study of EGFR oncogenic mutations in matching tissue and plasma samples from patients with advanced non-small cell lung carcinoma. Chai X; Ren P; Wei B; Ma J; Mai L; Cram DS; Song Y; Guo Y Clin Chim Acta; 2016 Jun; 457():106-11. PubMed ID: 27071701 [TBL] [Abstract][Full Text] [Related]
2. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer. He C; Zheng L; Xu Y; Liu M; Li Y; Xu J Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554 [TBL] [Abstract][Full Text] [Related]
3. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples. Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of Consistency in detection of epidermal growth factor receptor gene T790M mutation in plasma and tumor specimens of patients with lung adenocarcinoma]. Du J; Wang Z; Yang L; Di J; Zhang JG; Wang TY; Liu DG Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):35-39. PubMed ID: 29365415 [No Abstract] [Full Text] [Related]
5. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. Sequist LV; Martins RG; Spigel D; Grunberg SM; Spira A; Jänne PA; Joshi VA; McCollum D; Evans TL; Muzikansky A; Kuhlmann GL; Han M; Goldberg JS; Settleman J; Iafrate AJ; Engelman JA; Haber DA; Johnson BE; Lynch TJ J Clin Oncol; 2008 May; 26(15):2442-9. PubMed ID: 18458038 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology. Zhang S; Xia B; Jiang H; Wang L; Xu R; Shi Y; Zhang J; Xu M; Cram DS; Ma S Oncotarget; 2016 Aug; 7(31):50477-50489. PubMed ID: 27409166 [TBL] [Abstract][Full Text] [Related]
7. Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer. Zhu G; Ye X; Dong Z; Lu YC; Sun Y; Liu Y; McCormack R; Gu Y; Liu X J Mol Diagn; 2015 May; 17(3):265-72. PubMed ID: 25769900 [TBL] [Abstract][Full Text] [Related]
8. [Detection of epidermal growth factor receptor gene mutations in different types of non-small cell lung cancer by droplet digital PCR and amplification refractory mutation system]. Li R; Ye SB; He Y; Wang X; Wu N; Xia QY; Shen Q; Shi SS Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):764-768. PubMed ID: 29136689 [No Abstract] [Full Text] [Related]
9. A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma. Reckamp KL; Melnikova VO; Karlovich C; Sequist LV; Camidge DR; Wakelee H; Perol M; Oxnard GR; Kosco K; Croucher P; Samuelsz E; Vibat CR; Guerrero S; Geis J; Berz D; Mann E; Matheny S; Rolfe L; Raponi M; Erlander MG; Gadgeel S J Thorac Oncol; 2016 Oct; 11(10):1690-700. PubMed ID: 27468937 [TBL] [Abstract][Full Text] [Related]
10. Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Chu H; Zhong C; Xue G; Liang X; Wang J; Liu Y; Zhao S; Zhou Q; Bi J Oncol Rep; 2013 Nov; 30(5):2311-5. PubMed ID: 24002698 [TBL] [Abstract][Full Text] [Related]
11. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients. Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ Respiration; 2013; 85(2):119-25. PubMed ID: 22797485 [TBL] [Abstract][Full Text] [Related]
12. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer. He C; Liu M; Zhou C; Zhang J; Ouyang M; Zhong N; Xu J Int J Cancer; 2009 Nov; 125(10):2393-9. PubMed ID: 19530244 [TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR. Wang L; Guo Q; Yu W; Qiao L; Zhao M; Zhang C; Hu X; Yang G; Xiong L; Lou J Lung Cancer; 2017 Dec; 114():31-37. PubMed ID: 29173762 [TBL] [Abstract][Full Text] [Related]
14. Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood. Ran R; Li L; Wang M; Wang S; Zheng Z; Lin PP Anal Bioanal Chem; 2013 Sep; 405(23):7377-82. PubMed ID: 23828210 [TBL] [Abstract][Full Text] [Related]
15. EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial. Fassunke J; Ihle MA; Lenze D; Lehmann A; Hummel M; Vollbrecht C; Penzel R; Volckmar AL; Stenzinger A; Endris V; Jung A; Lehmann U; Zeugner S; Baretton G; Kreipe H; Schirmacher P; Kirchner T; Dietel M; Büttner R; Merkelbach-Bruse S Virchows Arch; 2017 Oct; 471(4):509-520. PubMed ID: 28884371 [TBL] [Abstract][Full Text] [Related]
16. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry. Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121 [TBL] [Abstract][Full Text] [Related]
17. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259 [TBL] [Abstract][Full Text] [Related]
18. Cross-Platform Comparison of Four Leading Technologies for Detecting Xu T; Kang X; You X; Dai L; Tian D; Yan W; Yang Y; Xiong H; Liang Z; Zhao GQ; Lin S; Chen KN; Xu G Theranostics; 2017; 7(6):1437-1446. PubMed ID: 28529628 [TBL] [Abstract][Full Text] [Related]
19. A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells. Molina-Vila MA; Bertran-Alamillo J; Reguart N; Taron M; Castellà E; Llatjós M; Costa C; Mayo C; Pradas A; Queralt C; Botia M; Pérez-Cano M; Carrasco E; Tomàs M; Mate JL; Moran T; Rosell R J Thorac Oncol; 2008 Nov; 3(11):1224-35. PubMed ID: 18978556 [TBL] [Abstract][Full Text] [Related]
20. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1). Beau-Faller M; Degeorges A; Rolland E; Mounawar M; Antoine M; Poulot V; Mauguen A; Barbu V; Coulet F; Prétet JL; Bièche I; Blons H; Boyer JC; Buisine MP; de Fraipont F; Lizard S; Olschwang S; Saulnier P; Prunier-Mirebeau D; Richard N; Danel C; Brambilla E; Chouaid C; Zalcman G; Hainaut P; Michiels S; Cadranel J J Thorac Oncol; 2011 Jun; 6(6):1006-15. PubMed ID: 21532509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]